Canine leishmaniasis vaccine
Leishmaniasis is a parasitic disease caused by the protozoan Leishmania and is transmitted by the bite of female midges. This zoonotic disease affects mainly dogs, causes serious veterinary problems and has a growing impact on public health.
Canileish, the first veterinary vaccine for leishmaniasis, was launched in Greece on Monday, 18 January. This vaccine comes to fill a gap in the prevention of the disease caused by the bite of an infected midge, as until now all precautionary measures were geared towards avoiding the bite.
The main difference between this vaccine and reality as we know it today is that it does not provide absolute immunity. When a puppy receives the parvovirus (typhoid) shot we know that the puppy will not develop parvovirus disease. However, a dog vaccinated with Canileish may develop leishmaniasis. What the vaccine does is to greatly reduce the chances of this happening.